Panthera has opened its expanded Glasgow Clinical Research Centre at the Health Innovation Hub, increasing capacity for ...
The ExoCordOA consortium has launched a five‑year, €13 million Horizon Europe project to advance extracellular ...
Hutchmed has confirmed that regulatory filings for Orpathys plus Tagrisso have been accepted for review in Europe and Japan.
Vertex Pharmaceuticals has secured MHRA authorisation and reimbursement for expanded use of Casgevy for eligible children aged 5 to under 12 years with severe sickle cell disease or ...
Johnson & Johnson has secured European Commission approval for an indication extension of teclistamab monotherapy for adults ...
The FDA has approved GSK’s Hibsago for adults with chronic hepatitis B virus infection who meet specific virological criteria ...
Hansa Biopharma has announced positive data from the European Post‑Authorization Efficacy and Safety study of Idefirix, ...
Hutchmed has announced positive phase 3 results from the SANOVO trial evaluating ORPATHYS plus TAGRISSO in treatment‑naïve ...
Sitryx Therapeutics has announced positive topline phase 1b results for SYX-5219, a first-in-class oral PKM2 modulator being ...
Patients with oligometastatic non‑small cell lung cancer lived significantly longer without disease progression when radiotherapy was added to standard systemic therapy, according to new phase 2 data ...
ViiV Healthcare has signed an agreement appointing Axmed as a non-exclusive distributor to support procurement and supply of ...
The FDA has approved Genentech’s Enspryng for adults with thyroid eye disease, making it the first at‑home subcutaneous ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results